Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

The Four-color FISH probe in the diagnosis of melanocytic lesions.

Boi S, Leonardi E, Fasanella S, Cantaloni C, Micciolo R.

J Eur Acad Dermatol Venereol. 2010 Oct;24(10):1235-6. doi: 10.1111/j.1468-3083.2010.03607.x. No abstract available.

PMID:
20236383
2.

Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.

Abásolo A, Vargas MT, Ríos-Martín JJ, Trigo I, Arjona A, González-Cámpora R.

Clin Exp Dermatol. 2012 Dec;37(8):838-43. doi: 10.1111/j.1365-2230.2012.04416.x. Epub 2012 Jun 25.

PMID:
22731835
3.

Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.

Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA.

Pathology. 2009;41(4):383-7. doi: 10.1080/00313020902915875.

PMID:
19404853
4.

Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.

Mudhar HS, Smith K, Talley P, Whitworth A, Atkey N, Rennie IG.

Br J Ophthalmol. 2013 Jan;97(1):40-6. doi: 10.1136/bjophthalmol-2012-302261. Epub 2012 Nov 8.

PMID:
23137666
5.

Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.

Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M.

Arch Dermatol. 2010 Mar;146(3):273-8. doi: 10.1001/archdermatol.2009.386.

PMID:
20231497
6.

Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.

Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ.

J Cutan Pathol. 2011 Apr;38(4):329-34. doi: 10.1111/j.1600-0560.2010.01666.x.

PMID:
21323721
7.

A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.

Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, Piris A, Mihm MC Jr.

Pathologica. 2009 Oct;101(5):169-74.

PMID:
20218056
8.

Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.

Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ.

Am J Surg Pathol. 2009 Dec;33(12):1783-8. doi: 10.1097/PAS.0b013e3181ba6db6.

PMID:
19809275
9.

Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.

Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P.

Am J Surg Pathol. 2009 Sep;33(9):1396-400. doi: 10.1097/PAS.0b013e3181a92cbc.

PMID:
19606012
10.

Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors.

Ponti G, Ruini C, Massi D, Pellacani G, Tomasi A, Paglierani M, Loschi P, Seidenari S.

Melanoma Res. 2013 Dec;23(6):474-80. doi: 10.1097/CMR.0000000000000020.

PMID:
24077512
11.

The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.

Ferrara G, Misciali C, Brenn T, Cerroni L, Kazakov DW, Perasole A, Russo R, Ricci R, Crisman G, Fanti PA, Passarini B, Patrizi A.

Int J Surg Pathol. 2013 Oct;21(5):483-92. doi: 10.1177/1066896913491323. Epub 2013 Jun 17.

PMID:
23775023
12.

Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.

Díaz A, Valera A, Carrera C, Hakim S, Aguilera P, García A, Palou J, Puig S, Malvehy J, Alos L.

Am J Surg Pathol. 2011 Nov;35(11):1733-42. doi: 10.1097/PAS.0b013e318229cf66.

PMID:
21997694
13.

Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.

Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH.

J Cutan Pathol. 2010 Feb;37(2):196-203. doi: 10.1111/j.1600-0560.2009.01488.x.

PMID:
20100177
14.

Update on fluorescence in situ hybridization in melanoma: state of the art.

Gerami P, Zembowicz A.

Arch Pathol Lab Med. 2011 Jul;135(7):830-7. doi: 10.1043/2011-0048-RAIR.1. Review. Erratum in: Arch Pathol Lab Med. 2011 Oct;135(10):1237.

PMID:
21732770
15.

Immunohistochemistry of melanocytic proliferations.

Prieto VG, Shea CR.

Arch Pathol Lab Med. 2011 Jul;135(7):853-9. doi: 10.1043/2009-0717-RAR.1. Review.

PMID:
21732774
16.

Lentiginous melanoma: a histologic pattern of melanoma to be distinguished from lentiginous nevus.

King R, Page RN, Googe PB, Mihm MC Jr.

Mod Pathol. 2005 Oct;18(10):1397-401.

17.

Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.

Zembowicz A, Yang SE, Kafanas A, Lyle SR.

Arch Pathol Lab Med. 2012 Dec;136(12):1571-9. doi: 10.5858/arpa.2011-0673-OA. Epub 2012 Apr 5.

PMID:
22480223
18.

Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.

Gaiser T, Kutzner H, Palmedo G, Siegelin MD, Wiesner T, Bruckner T, Hartschuh W, Enk AH, Becker MR.

Mod Pathol. 2010 Mar;23(3):413-9. doi: 10.1038/modpathol.2009.177. Epub 2010 Jan 15.

19.

The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.

Demirkan NC, Kesen Z, Akdag B, Larue L, Delmas V.

Clin Exp Dermatol. 2007 Nov;32(6):733-9. Epub 2007 Sep 14.

PMID:
17868395
20.

[The DNA and sex chromatin in pigmented skin neoplasms in man].

Naleskina LA.

Vopr Onkol. 1971;17(4):8-14. Russian. No abstract available.

PMID:
5564886

Supplemental Content

Support Center